Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma
Advanced Science · 2026-11 · 13 (62)
DOI: 10.1002/advs.77174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 18.08.2026. Verfasst von Yiwen Lv und 16 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, Berberine, Multiple Myeloma, Bortezomib. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Science and Technology Plan Project, Foundation of Guangdong Second Provincial General Hospital, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Therapeutic relapse driven by bortezomib resistance represents a formidable clinical barrier in the management of multiple myeloma (MM). Here, a carrier‐free, supramolecular nanoplatform was engineered through the spontaneous co‐assembly of two natural alkaloids, berberine (BBR) and nitidine chloride (NC), termed BBR/NC‐SAPs, to counter this malignancy. Driven by cooperative π‐π stacking and van der Waals forces, BBR/NC‐SAPs display superior anti‐MM efficacy and optimized biosafety as compared to the free‐drug combination. Quantitative proteomics and functional landscapes showed that BBR/NC‐SAPs robustly activate iron‐dependent ferroptosis, as evidenced by massive lipid peroxidation, intracellular Fe 2+ overload, and mitochondrial depolarization. Mechanistically, integrated target deconvolution and atomistic molecular modeling identified NR2F2 as a direct target of BBR/NC‐SAPs. Functional knock‐out and rescue evaluations definitively validated that NR2F2 is an essential mediator governing the therapeutic response, as NR2F2 depletion occluded the ferroptotic cascade, and lentiviral reconstitution fully restored cellular sensitivity and GPX4‐associated ferroptosis activation. Further, BBR/NC‐SAPs markedly suppressed tumor growth and prolonged survival in bortezomib‐resistant MM xenograft models, a therapeutic benefit actively reversed by the ferroptosis inhibitor ferrostatin‐1. Collectively, this work highlights a paradigm of natural product‐derived nanotechnology that targets the NR2F2–GPX4 axis, offering a promising supramolecular strategy to overcome drug resistance in refractory hematological tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
- The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, People's Republic of China.
- Key Laboratory of Regenerative Medicine of Ministry of Education, Guangzhou, Guangdong, People's Republic of China.
- Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, People's Republic of China.
ORCID-Profile: Yiwen Lv, Shuang Liu, Jing Huang, Pei Lin, Qing Zhang, Guopan Yu, Zhao Yin
Förderung
- Guangzhou Science and Technology Plan Project
- Foundation of Guangdong Second Provincial General Hospital
- Guangdong Basic and Applied Basic Research Foundation
- Traditional Chinese Medicine of Guangdong Province
- Guangdong Medical Science and Technology Research
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Lv, Y., Liu, S., Wu, H., Li, G., Rong, Y., Li, G., Zhu, Y., Zhong, Q., Ou, R., Shen, H., Liu, Z., Huang, J., Wang, Z., Lin, P., Zhang, Q., Yu, G., & Yin, Z. (2026). Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma. Advanced Science, 13(62). https://doi.org/10.1002/advs.77174
Vancouver
Lv Y, Liu S, Wu H, Li G, Rong Y, Li G, et al. Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma. Advanced Science. 2026;13(62). doi:10.1002/advs.77174
BibTeX
@article{Lv2026,
author = {Lv, Yiwen and Liu, Shuang and Wu, Hong and Li, Guiluan and Rong, Ying and Li, Guangchao and Zhu, Yangmin and Zhong, Qi and Ou, Ruiming and Shen, Huijuan and Liu, Zhi and Huang, Jing and Wang, Zhenwei and Lin, Pei and Zhang, Qing and Yu, Guopan and Yin, Zhao},
title = {Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {62},
doi = {10.1002/advs.77174}
}
EUVIMED